Amgen Inc. (AMGN): A Bull Case Theory [Yahoo! Finance]
Amgen Inc. (AMGN)
Last amgen inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.amgen.com
Company Research
Source: Yahoo! Finance
A pharmacy shelves stocked with pharmaceutical drugs awaiting distribution. Amgen, a rare biotech company in the Dow index, is well-known for its flagship drug EPO, but its growth today stems from a diversified portfolio across general medicine, inflammation, oncology, and rare diseases. Its portfolio includes 12 drugs growing by double digits, notably Prolia for osteoporosis, with many growth drivers coming from its acquisition of Horizon Therapeutics. This acquisition has expanded Amgen's reach into oncology and rare diseases, making its product lineup even more robust. Financially, Amgen is expected to grow its revenue by nearly 20% this year, largely due to the Horizon acquisition. However, some analysts predict a slowdown from 2025, which seems overly pessimistic given Amgen's strong drug pipeline. The company is likely to continue growing at 4% annually in 2025 and 2026, with MariTide offering additional upside if the trials go well. In 2024, Amgen has guided for around $33
Show less
Read more
Impact Snapshot
Event Time:
AMGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMGN alerts
High impacting Amgen Inc. news events
Weekly update
A roundup of the hottest topics
AMGN
News
- Erythropoietin Drugs Market Estimated to Reach USD 14.3 billion, Advancing at a CAGR of 3.8% by 2034: Transparency Market Research Inc. [Yahoo! Finance]Yahoo! Finance
- Women's Reproductive Health Market (2024 Edition): Market Insights and Forecast (2020-2030) Featuring Profiles of Amgen, Teva Pharma, Merck & Co, Bayer, AbbVie [Yahoo! Finance]Yahoo! Finance
- Amgen (AMGN) Stock Dips While Market Gains: Key Facts [Yahoo! Finance]Yahoo! Finance
- Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know [Yahoo! Finance]Yahoo! Finance
- Is Amgen Inc. (NASDAQ:AMGN) Trading At A 42% Discount? [Yahoo! Finance]Yahoo! Finance
AMGN
Earnings
- 8/6/24 - Beat
AMGN
Sec Filings
- 8/13/24 - Form 4
- 8/13/24 - Form 4
- 8/13/24 - Form 4
- AMGN's page on the SEC website